The Effect of Omega -3 Supplements on the Serum Levels of ACE/ACE2 Ratio as a Potential Key in Cardiovascular Disease and COVID-19; A Randomized Clinical Trial in the Covid-19 Uninfected Jordanian People
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Cardiovascular Risk Factor
- COVID-19
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Single (Participant)Primary Purpose: Prevention
Participation Requirements
- Age
- Between 35 years and 65 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04658433
- Collaborators
- Not Provided
- Investigators
- Study Chair: Mahmoud S Abu-Samak, PhD Department of Clinical Pharmacy and Therapeutics , Applied Science Private University, Amman -Jordan Principal Investigator: Sara M Daboul, MSC Department of Clinical Pharmacy and Therapeutics , Applied Science Private University, Amman -Jordan